Clinical trial
Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease…
NCT00159835 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00159835 |
|---|---|
| Title | Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD |
| Official title | Atorvastatin Compared With Simvastatin In The Prevention of CHD Morbidity And Mortality In Patients With CHD |
| Acronym | IDEAL |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | atorvastatin, simvastatin |
| Enrollment | 8,600 |
| Start date | Feb 1, 1999 |
| Completion | Mar 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 22, 2015 |
| Countries | Denmark, Finland, Iceland, Netherlands, Norway, Sweden |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: